Health · Guinea-Bissau
Police in Guinea-Bissau Raid Offices of Researchers Behind Disputed Newborn Hepatitis B Vaccine Trial
By: Ola Badawy
Judicial police in Guinea-Bissau searched the offices of researchers linked to a contested newborn hepatitis B vaccine trial and seized vaccine doses. Officials said the seizure does not indicate quality or safety problems, while the health minister disputed that the study will go ahead.
Judicial police in Guinea-Bissau have searched the offices of researchers at the centre of a dispute over a planned vaccine trial on newborns, seizing doses of hepatitis B vaccine, officials said in a Facebook post.
The search took place on Monday and involved "investigative procedures aimed at clarifying the circumstances related to the said batch of vaccines", according to the post, which was translated from Portuguese. The announcement stated that seizing the vaccines does not point to "irregularities in the quality, safety, or effectiveness of the vaccines".
The researchers, from the Bandim Health Project, are behind a study backed by $1.6m from the US Centers for Disease Control and Prevention, matched by the Pershing Square Foundation and the Bluebell Foundation, for a total of $3.2m. The redesigned trial would withhold hepatitis B vaccine from 7,000 newborns during their first six weeks of life, in a country where about one in five adults has the virus.
The project recently published an approval letter dated 14 July from the national ethics committee at the health ministry. A Danish research ethics committee also approved the study earlier this month. However, Health Minister Quinhin Nantote of the transitional government rejected reports that the trial will proceed, saying: "This is not even remotely true."
A World Health Organization spokesperson, Tarik Jašarević, said any study denying the vaccine to participants is "unethical and exposes newborns to serious and potentially irreversible harm". He described birth-dose vaccination as an essential public health intervention. The WHO has been advising the ministry on introducing the vaccine and on the study's potential impact.
Bandim's leaders, including Peter Aaby, Christine Stabell Benn and lead researcher Frederik Schaltz-Buchholzer, did not respond to questions about the trial and the search. US Health Secretary Robert F Kennedy Jr has previously praised their work.
Colette Delawalla, founder of the nonprofit Stand Up for Science, said the raid reflected the fragility of Guinea-Bissau, which had a military coup less than a year ago.